MedTrace Logo

Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture

NCT02996253 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2023-03-22

No results posted yet for this study

Summary

The transfer of Flexor Hallucis Longus (FHL) in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome, but an extensive surgical field at a vulnerable location may lead to increased risk for soft tissue problems. The arthroscopic FHL transfer may reduce the risk for soft tissue problems. Functional outcome parameters are investigated, wound/soft tissue complications registered.

Conditions

  • Achilles Tendon Rupture

Interventions

PROCEDURE

FHL transfer

endoscopic transfer og flexor hallucis longus

Sponsors & Collaborators

  • Central Hospital, Fredrikstad

    collaborator UNKNOWN

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Elisabeth E Husebye, MD, PhD · Oslo University Hospital

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2022-02-28
Completion
2024-02-29

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02996253 on ClinicalTrials.gov